Venetoclax: Will It Be Approved for 11Q Deletion Patients?

Could venetoclax be used soon for patients with 11q deletion? Dr. Nicole Lamanna of Columbia University Medical Center, answers a viewer’s question in this “Ask the Expert” segment. Venetoclax (Venclexta) is currently approved for 17p deletion according to Dr. Lamanna, “It’s coming” for additional groups of patients.

Get email alerts | http://www.patientpower.info/alerts

Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo